Michel Marre Selected Research

Insulin Glargine (Lantus)

7/2014	Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.
12/2013	Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes.
4/2012	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Marre Research Topics

Disease

105	Type 2 Diabetes Mellitus (MODY) 03/2024 - 08/2002
34	Vascular Diseases (Vascular Disease) 03/2024 - 04/2009
25	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 03/2001
24	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2001
24	Insulin Resistance 11/2021 - 04/2004
21	Hypertension (High Blood Pressure) 01/2023 - 03/2003
18	Obesity 01/2023 - 04/2004
14	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 03/2003
13	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 06/2007
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2016 - 04/2004
10	Proteinuria 10/2019 - 03/2001
10	Hyperglycemia 09/2013 - 03/2004
9	Body Weight (Weight, Body) 10/2020 - 08/2002
8	Albuminuria 12/2016 - 03/2003
7	Chronic Renal Insufficiency 11/2023 - 05/2013
7	Myocardial Infarction 01/2022 - 04/2008
7	Hypoglycemia (Reactive Hypoglycemia) 09/2018 - 05/2009
6	Diabetes Complications 10/2021 - 11/2004
6	Diabetes Mellitus 01/2019 - 03/2003
6	Weight Gain 01/2018 - 05/2009
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 11/2004
5	Stroke (Strokes) 01/2022 - 07/2012
5	Kidney Diseases (Kidney Disease) 01/2018 - 01/2014
4	Genetic Risk Score 10/2021 - 08/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 07/2010
3	Diabetic Foot 01/2023 - 01/2016
3	COVID-19 01/2023 - 01/2021
3	Heart Failure 01/2022 - 11/2010
3	Weight Loss (Weight Reduction) 10/2020 - 05/2013
3	Glucose Intolerance 09/2015 - 07/2007
3	Ischemia 09/2015 - 01/2011
2	Ulcer 01/2023 - 01/2016
2	Renal Insufficiency (Renal Failure) 01/2022 - 05/2013
2	Nausea 10/2020 - 05/2009
2	Foot Ulcer 12/2019 - 01/2016
2	Hypotension (Low Blood Pressure) 11/2019 - 01/2017
2	Coronary Disease (Coronary Heart Disease) 12/2018 - 01/2009
2	Morbid Obesity 04/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

56	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 03/2004
36	Gliclazide (Diamicron)IBA 03/2024 - 06/2008
34	perindopril drug combination indapamideIBA 03/2024 - 04/2009
29	Insulin (Novolin)FDA Link 01/2023 - 04/2006
19	CreatinineIBA 01/2022 - 03/2001
13	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2006
13	AlbuminsIBA 01/2022 - 03/2003
10	LipidsIBA 01/2021 - 08/2002
9	Ramipril (Altace)FDA LinkGeneric 07/2016 - 02/2004
8	HDL CholesterolIBA 03/2024 - 11/2006
8	Perindopril FDA LinkGeneric 01/2022 - 09/2007
8	Indapamide FDA LinkGeneric 01/2022 - 08/2004
8	AdiponectinIBA 11/2021 - 04/2004
8	Hypoglycemic Agents (Hypoglycemics)IBA 09/2018 - 02/2004
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 02/2004
6	Vasopressins (Vasopressin)IBA 01/2018 - 03/2003
5	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 08/2002
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2020 - 06/2008
5	EnzymesIBA 10/2015 - 04/2007
5	Proteins (Proteins, Gene)FDA Link 06/2010 - 07/2007
4	CholesterolIBA 12/2023 - 07/2007
4	Advanced Oxidation Protein Products (AOPP)IBA 02/2016 - 01/2014
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2007 - 03/2001
3	Glucagon-Like Peptide-1 ReceptorIBA 10/2023 - 09/2013
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 11/2009
3	AdrenomedullinIBA 01/2022 - 09/2015
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 06/2007
3	Liraglutide FDA Link 10/2020 - 05/2009
3	8-Hydroxy-2'-DeoxyguanosineIBA 01/2020 - 01/2018
3	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 08/2004
3	Peptides (Polypeptides)IBA 12/2018 - 04/2004
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 08/2008
3	omega-Chloroacetophenone (Mace)IBA 01/2018 - 07/2016
3	Superoxide DismutaseIBA 01/2015 - 12/2011
3	Insulin Glargine (Lantus)FDA Link 07/2014 - 04/2012
3	KininsIBA 05/2014 - 08/2009
3	Transcription Factors (Transcription Factor)IBA 02/2009 - 08/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2004 - 02/2002
2	AutoantibodiesIBA 01/2023 - 04/2011
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 09/2016
2	DiureticsIBA 01/2019 - 08/2004
2	Vasodilator Agents (Vasodilators)IBA 12/2018 - 09/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2018 - 08/2014
2	pro-brain natriuretic peptide (1-76)IBA 12/2018 - 08/2014
2	H-cadherin (T-cadherin)IBA 12/2017 - 12/2017
2	Retinaldehyde (Retinal)IBA 10/2016 - 01/2016
2	glimepiride (Amarel)FDA LinkGeneric 04/2016 - 05/2009
2	IsoprostanesIBA 02/2016 - 01/2015
2	KynurenineIBA 01/2016 - 10/2015
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2016 - 10/2015
2	CytokinesIBA 10/2015 - 02/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015 - 12/2011
2	Tissue Kallikreins (Tissue Kallikrein)IBA 05/2014 - 08/2009
2	Kallikreins (Kallikrein)IBA 05/2014 - 08/2009
2	Fibrinogen (Factor I)FDA Link 03/2014 - 06/2006

Therapy/Procedure

21	Therapeutics 03/2024 - 08/2004
9	Surgical Amputation (Amputations) 01/2022 - 01/2015
8	Glycemic Control 03/2024 - 06/2008
5	Kidney Transplantation 01/2019 - 07/2012
2	Precision Medicine 01/2023 - 10/2020
2	Orthotic Devices (Orthosis) 01/2020 - 01/2016
2	Light Coagulation 10/2016 - 01/2016